DAVID MUNYAN: Open Payments
NPI 1336862721 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $583 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| COLOPLAST CORP | 1 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56 |
| Novo Nordisk Inc | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Exact Sciences Corporation | 2 | $30 |
| Dexcom, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
Products named: AUSTEDO XR, Titan, AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, OFEV, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across KS — which companies pay providers there.
